2,248
Participants
Start Date
March 25, 2021
Primary Completion Date
May 5, 2025
Study Completion Date
May 5, 2025
Shortened DAPT followed by P2Y12 inhibitor monotherapy (cessation of aspirin)
Subjects will receive DAPT during 1 month post procedure, followed by P2Y12 inhibitor monotherapy (cessation of aspirin) for the next 11 months
Standard DAPT
Subjects will receive standard treatment: P2Y12 inhibitor and aspirin (DAPT) during 12 months after procedure
Universitätsklinikum, Sankt Pölten
CHU Annecy, Annecy
Clinique Roseraie, Aubervilliers
CH Bastia, Bastia
CHU Caen, Caen
CH Chartres, Chartres
CH Cherbourg, Cherbourg
CHU Clermont-Ferrand, Clermont-Ferrand
CHU Dijon, Dijon
CH Haguenau, Haguenau
CHU Lille, Lille
CH St Joseph/St Luc, Lyon
CHU La Timone, Marseille
Hôpital Jacques Cartier, Massy
CHU Montpellier, Montpellier
Clinique Millénaire, Montpellier
CHU Nîmes, Nîmes
CHU Reims, Reims
Clinique St Hilaire, Rouen
CHU Toulouse, Toulouse
Clinique Pasteur, Toulouse
Humanitas - Gavazzeni, Bergamo
Clinica Montevergine, Mercogliano
Niguarda, Milan
AOU Federico II, Napoli
Policlinico Universitario, Padua
Giovanni Paolo II, Ragusa
Jeroen Bosch Ziekenhuis, 's-Hertogenbosch
Tergooi MC, Blaricum
Albert Schweitzer Ziekenhuis, Dordrecht
Maastad University Hospital, Rotterdam
Haga Ziekenhuis, The Hague
Hospital Santa Maria, Lisbon
Hospital General Universitario, Alicante
Clinic Hospital Barcelona, Barcelona
Hospital del Mar, Barcelona
Puerta del mar, Cadiz
Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat
Hosp. Doctor Lucus Augusti, Lugo
Hospital Universitario La Princesa, Madrid
Lead Sponsor
European Cardiovascular Research Center
NETWORK
MicroPort CRM
INDUSTRY